CLINICAL_TRIALS
trial_result
· 2025-11-14
Clinical Trial Update: IAI Versus Sham as Prophylaxis Against Conversion to Neovascular AMD [Phase 2]
Summary
Phase 2 trial comparing IAI to sham prophylaxis to prevent conversion to neovascular Age-Related Macular Degeneration; results from the completed study have bee…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jeffrey S Heier | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2025-11-14